Détails sur le projet
Description
DESCRIPTION: (Applicant's Description) Dietary antioxidants may protect
cigarette smokers from the initiating events in chemical carcinogenesis. To
test this hypothesis, we are currently carrying out a study using biological
markers as intermediate endpoints to test the efficacy of an antioxidant
vitamin intervention in 100 heavy smokers. After a one month run-in period,
eligible, compliant subjects are randomly assigned to one of two treatment
groups: 1, 500 mg vitamin C, 12 mg -carotene and 400 IU vitamin E
(a-tocopherol) per day and 11, placebo. Blood, buccal cells and urine
samples are being collected upon enrollment and at 1, 3, and 6 months.
Funds are currently available for analysis of: 1) polycyclic aromatic
hydrocarbon (PAH)-DNA adducts in mononuclear cells by a competitive
enzyme-linked immunosorbent assay (ELISA) using a polyclonal antiserum which
recognizes benzo(a)pyrene and structurally related PAH diol epoxide DNA
adducts; 2) smoking status by measurement of plasma cotinine; and 3) several
antioxidant vitamins measured by reverse-phase HPLC (retinol, tocopherols)
or spectrophotometry (ascorbic acid). We have recently developed sensitive
immunoperoxidase methods for quantitation of PAH-DNA,
8-hydroxydeoxyguanosine (8OHdG) and 4-amino biphenyl (4-ABP)-DNA. For this
reason, additional funds are requested for analysis of PAH-DNA and 8OHdG in
oral cells and 4-ABP-DNA in exfoliated bladder cells by immunoperoxidase
staining. In addition, we have data suggesting that serum levels of
antioxidant vitamins have a protective effect on mononuclear cell PAH-DNA
adducts only in smokers who lack the glutathione S-transferase Ml gene.
Thus, we propose to also genotype subjects for GSTM1 and GSTT1, transferases
deleted in a large percentage of the population. The demonstration that DNA
damage can be modulated in target tissues for smoking induced cancers by
dietary antioxidants will provide important information justifying their use
as intermediate biomarkers in intervention studies.
Statut | Terminé |
---|---|
Date de début/de fin réelle | 9/30/96 → 7/31/99 |
Financement
- National Cancer Institute
Keywords
- Investigación sobre el cáncer
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.